Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Joseph Edelman’s Perceptive Advisors Buys More AcelRx Pharmaceuticals

Joseph Edelman‘s fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again, after disclosing a buy of around 360,700 shares a couple of days ago. This time, Perceptive acquired 155,000 shares, bringing the position to a total of some 6.37 million shares. The average purchase price amounts to around $6.87 per share.

AcelRx Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Heartland Advisors Discloses Changes in its Albany International and Gulf Island Holdings

Bill Ackman Cuts Stake in LSE-listed Platform Specialty Products

Chuck Royce Discloses Moves in Vera Bradley, Graham Corp & Others

Loading...